QT Imaging Holdings, Inc.

QTI

$2.74

-0.36%

N/A-$0.01

Healthcare

Medical - Devices

NASDAQ

Active Trading

QT Imaging Holdings, Inc. is dedicated to the research, development, and manufacturing of advanced automated systems for breast imaging. These innovative devices ...

Recent News of QTI

Business Wire8/5/2026Neutral

QT Imaging to Report Second Quarter 2026 Financial Results and Host Conference Call on August 12, 2026

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that it will report financial results for the second quarter ended June 30, 2026, after market close on Wednesday, August 12, 2026, and will host a conference call beginning at 4:30 p.m. Eastern Time. Participants are encouraged to pre-register a.

Business Wire8/4/2026Neutral

QT Imaging Advances Direct U.S. Commercial Strategy to Accelerate Adoption of its Breast Acoustic CT Scanner with Two Key Hires

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today advanced the direct U.S. commercial strategy for its Breast Acoustic CT™ Scanner with the appointment of Jason Dyer as Vice President Regional Sales East and Dave Reinhart as Vice President Regional Sales West. Both executives joined QT Imaging in July 202.

Business Wire7/29/2026Neutral

QT Imaging Appoints Medical Imaging and Digital Health Executive Dr. Julia Albright as Chief Science Officer

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced the appointment of Julia Albright, Ph.D., as Chief Science Officer (“CSO”), effective July 27, 2026. Dr. Albright brings more than 25 years of experience spanning medical imaging, digital health, oncology, cloud technologies, and the development.

Business Wire7/28/2026Neutral

QT Imaging Holdings Announces Results of 2026 Annual Stockholder Meeting

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (“QT Imaging” or the “Company”) (NASDAQ: QTI), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, announced today that at the Annual Meeting of Company's stockholders (the “Annual Meeting”) held on July 28, 2026, the Company's stockholders voted to approve (i) the election of Professor Zeev Weiner and Bryan Timm as Class II directors to serve until the Compan.

GuruFocus7/28/2026Neutral

QT Imaging Receives Israeli Ministry of Health Regulatory Registration

[url="]QT Imaging Holdings, Inc.[/url](Nasdaq: QTI) (âQT Imagingâ or the âCompanyâ), a medical device company dedicated to transforming breast health ma

QT Imaging Holdings, Inc.

Recent News of QTI

QT Imaging to Report Second Quarter 2026 Financial Results and Host Conference Call on August 12, 2026

QT Imaging Advances Direct U.S. Commercial Strategy to Accelerate Adoption of its Breast Acoustic CT Scanner with Two Key Hires

QT Imaging Appoints Medical Imaging and Digital Health Executive Dr. Julia Albright as Chief Science Officer

QT Imaging Holdings Announces Results of 2026 Annual Stockholder Meeting

QT Imaging Receives Israeli Ministry of Health Regulatory Registration

QT Imaging to Report Second Quarter 2026 Financial Results and Host Conference Call on August 12, 2026

QT Imaging Advances Direct U.S. Commercial Strategy to Accelerate Adoption of its Breast Acoustic CT Scanner with Two Key Hires

QT Imaging Appoints Medical Imaging and Digital Health Executive Dr. Julia Albright as Chief Science Officer

QT Imaging Holdings Announces Results of 2026 Annual Stockholder Meeting

QT Imaging Receives Israeli Ministry of Health Regulatory Registration

QT Imaging Receives Israeli Ministry of Health Regulatory Registration

QT Imaging Announces Successful Completion of First FDA Routine Inspection with Zero Form 483 Observations

QT Imaging's CEO Presents Sports Shiftmaker Award to Tennis Champion and Breast Cancer Survivor Martina Navratilova During Wimbledon Week

A New Standard of Reproducibility for Quantitative Biomarkers in Breast Imaging

QT Imaging Receives Saudi Arabia FDA Regulatory Clearance

QT Imaging Set to Join the Russell Microcap® Index

QT Imaging Set to Join the Russell Microcap® Index

QT Imaging Holdings Announces Closing of $10 Million Underwritten Public Offering

QT Imaging Holdings Announces Pricing of $10 Million Underwritten Public Offering

QT Imaging Holdings Announces Pricing of $10 Million Underwritten Public Offering